10x Genomics
256 hedge funds and large institutions have $5.03B invested in 10x Genomics in 2023 Q1 according to their latest regulatory filings, with 39 funds opening new positions, 85 increasing their positions, 81 reducing their positions, and 47 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
256
Holders Change
-10
Holders Change %
-3.76%
% of All Funds
4.1%
Holding in Top 10
7
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+40%
% of All Funds
0.11%
New
39
Increased
85
Reduced
81
Closed
47
Calls
$30.7M
Puts
$10.9M
Net Calls
+$19.9M
Net Calls Change
+$16.1M
Top Buyers
| 1 |
BCM
Brown Capital Management
Baltimore,
Maryland
|
+$90.5M |
| 2 |
Invesco
Atlanta,
Georgia
|
+$88.7M |
| 3 |
Fidelity Investments
Boston,
Massachusetts
|
+$65.3M |
| 4 |
Lord, Abbett & Co
Jersey City,
New Jersey
|
+$58.6M |
| 5 |
T. Rowe Price Investment Management
Baltimore,
Maryland
|
+$57.2M |
Top Sellers
| 1 |
Millennium Management
New York
|
-$55.2M |
| 2 |
CS
Credit Suisse
Zurich,
Switzerland
|
-$39.8M |
| 3 |
FCMI
Foresite Capital Management II
Larkspur,
California
|
-$36.3M |
| 4 |
Wolverine Trading
Chicago,
Illinois
|
-$34.2M |
| 5 |
Man Group
London,
United Kingdom
|
-$19.8M |
